GlobalData

★GlobalData社の人気レポート・最新レポートはこちら★

世界の産業動向ニュース

薬剤溶出ステント（DES）の世界市場：医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Drug Eluting Stents (DES) – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Drug Eluting Stents (DES) – Medical Devices Pipeline Assessment, 2016″ provides an overview of Drug Eluting Stents (DES) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drug Eluting Stents (DES) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Drug Eluting Stents (DES) under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Drug Eluting Stents (DES) and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Drug Eluting Stents (DES) under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

世界の産業動向ニュース

乾癬性関節炎治療の世界市場：医薬品予測・市場分析（～2025）

2017年3月6日 // 0 Comments

PharmaPoint: Psoriatic Arthritis – Global Drug Forecast and Market Analysis to 2025
Summary

Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially those of the lower extremities and distal joints of the fingers and toes as well as the back and sacroiliac joints of the pelvis. In approximately 80% of PsA patients, skin lesions of psoriasis (PsO), an immune-mediated skin disease, manifest prior to the development of PsA, typically by five to 10 years. PsA most commonly develops between the ages of 30 and 50 and affects men and women equally. Although, early diagnosis and intervention are key in preventing irreversible joint damage, many PsA patients are undiagnosed and go untreated for months or years.

GlobalData projects the PsA market in 7MM to experience strong growth during the forecast period at a CAGR of 10.74%. By the forecast’s end in 2025, sales will increase to over $12.58 billion from $4.53 billion in 2015. This growth will be driven primarily by the increase in diagnosed prevalent cases from 1,044,022 in 2015 to 1,520,471 in 2025. Further, the launch of the IL-17 inhibitors, including Novartis’ Cosentyx, Eli Lilly’s Taltz, and AstraZeneca’s Lumicef, as well as the launch of Celgene’s oral therapy Otezla, will expand the treatment armamentarium for PsA driving growth in the market.

Highlights

Key Questions Answered

– How large an impact will biosimilars have on the PsA market? What do dermatologists, rheumatologists, and key opinion leaders across the 7MM think about the evolving treatment landscape?
– What opportunities remain in the market for new product entrants?
– What are the most promising late-stage pipeline drugs and how will their launch shape the future treatment landscape in the PsA market?
– According to KOLs, what are the most important unmet needs in PsA? Will these needs be addressed by pipeline agents? What needs will remain by the end of the forecast period in 2025?
– What clinical and commercial factors are likely to affect uptake of PsA therapies in the US, 5EU, and Japan?

Key Findings

– The PsA market is currently very dynamic, with effective biologic therapies recently approved, including interleukin-17 (IL-17) inhibitors – Cosentyx, Taltz, and Lumicef – and oral phosphodiesterase-4 (PDE4) – Otezla.
– Novel biologic therapies will challenge the current anti-TNF biologics in an attempt to dislodge their stronghold, if their safety and efficacy profiles are proven once they enter the market.
– The impending patent cliff for biologics will allow for the emergence of biosimilars to all the marketed biologic brands. Patent expiries take place during the forecast period for the current market leaders such as Johnson & Johnson’s Remicade (infliximab), AbbVie’s Humira (adalimumab), Amgen’s Enbrel (etanercept) and Johnson & Johnson’s Stelara (ustekinumab).
– The drivers for market growth will include the increasing diagnosis rate as well as the recent approval of novel therapies. The main challenge for individual drugs will be to distinguish themselves in a crowded marketplace, comprising a highly diversified field of therapies, with existing drugs struggling to increase their patient share.

Scope

– Overview of PsA, including epidemiology, etiology, pathophysiology, symptoms and country-specific diagnosis and treatment recommendations.
– Annualized PsA market revenue, annual cost of therapy and treatment usage pattern data from 2015 and forecast for ten years to 2025.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs, and implications for the PsA market.
– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of novel products- including promising IL-17 inhibitors – and biosimilars – such as Celltrion’s Hospira, Sandoz’s Erelzi, Biogen/Samsung Bioepies’ Flixabi and Benepali, and Amgen’s Amjevita.
– Analysis of the current and future market competition in the global PsA market (7MM). Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to –
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global Psoriasis market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Psoriasis market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track drug sales in the global PsA market from 2015-2025.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

世界の産業動向ニュース

人工心臓（VAD）の世界市場：医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Ventricular Assist Devices – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Ventricular Assist Devices – Medical Devices Pipeline Assessment, 2016″ provides an overview of Ventricular Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ventricular Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Ventricular Assist Devices under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Ventricular Assist Devices and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Ventricular Assist Devices under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

世界の産業動向ニュース

経皮吸収型ドラッグデリバリーの世界市場：医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Transdermal Drug Delivery – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Transdermal Drug Delivery – Medical Devices Pipeline Assessment, 2016″ provides an overview of Transdermal Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Transdermal Drug Delivery under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Transdermal Drug Delivery and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Transdermal Drug Delivery under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

世界の産業動向ニュース

腎透析機器の世界市場：医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Renal Dialysis Equipment – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Renal Dialysis Equipment – Medical Devices Pipeline Assessment, 2016″ provides an overview of Renal Dialysis Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Renal Dialysis Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Renal Dialysis Equipment under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Renal Dialysis Equipment and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Renal Dialysis Equipment under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

世界の産業動向ニュース

末梢血管用ステントの世界市場：医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Peripheral Vascular Stents – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Peripheral Vascular Stents – Medical Devices Pipeline Assessment, 2016″ provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Vascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Peripheral Vascular Stents under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Peripheral Vascular Stents under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

世界の産業動向ニュース

脳深部刺激機器の世界市場：医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Deep Brain Stimulators – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Deep Brain Stimulators – Medical Devices Pipeline Assessment, 2016″ provides an overview of Deep Brain Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Deep Brain Stimulators under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Deep Brain Stimulators and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Deep Brain Stimulators under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

世界の産業動向ニュース

持続血糖測定（CGM）システムの世界市場：医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Continuous Glucose Monitoring Systems – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Continuous Glucose Monitoring Systems – Medical Devices Pipeline Assessment, 2016″ provides an overview of Continuous Glucose Monitoring Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Continuous Glucose Monitoring Systems under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Continuous Glucose Monitoring Systems under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

世界の産業動向ニュース

心臓弁修復の世界市場：医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Cardiac Valve Repairs – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Cardiac Valve Repairs – Medical Devices Pipeline Assessment, 2016″ provides an overview of Cardiac Valve Repairs currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Valve Repairs pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Cardiac Valve Repairs under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Cardiac Valve Repairs and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Cardiac Valve Repairs under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

世界の産業動向ニュース

先進創傷治療の世界市場：医療機器パイプライン分析2016

2017年3月6日 // 0 Comments

Advanced Wound Management – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Advanced Wound Management – Medical Devices Pipeline Assessment, 2016″ provides an overview of Advanced Wound Management currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Advanced Wound Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Advanced Wound Management under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Advanced Wound Management and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Advanced Wound Management under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

世界の産業動向ニュース

ガス絶縁開閉装置（GIS）の世界市場2016：市場規模、競争環境、主要国分析、予測

2017年3月6日 // 0 Comments

Gas Insulated Switchgear Market, Update 2016 – Global Market Size, Competitive Landscape, Key Country Analysis and Forecasts to 2020
Summary

GlobalData’s latest report “Gas Insulated Switchgear Market, Update 2016 – Global Market Size, Competitive Landscape, Key Country Analysis and Forecasts to 2020” provides comprehensive information and understanding of the GIS market. The report offers in-depth analysis of GIS market at global, regional (Asia-Pacific, Americas, Europe, and Middle East and Africa) and key countries (the US, Canada, Germany, the UK, France, Saudi Arabia, China, India, Japan and Australia) level. The report analyzes the global and regional GIS market value and volume by voltage segment for the historic (2010-2015) and forecast (2016-2020) periods. The report also offers the country-level analysis of GIS market value and volume by voltage segment for the historic and forecast periods. The report covers the drivers and restraints affecting the GIS market and the competitive landscape for respective countries in 2015. The report is built using data and information sourced from primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report analyses GIS market. It includes –
– Analysis of the growth of GIS market with a focus on market value and volume in global and regional level including Asia-Pacific, Americas, Europe, and Middle East and Africa.
– The report provides GIS market analysis for key countries including the US, Canada, Germany, the UK, France, Saudi Arabia, China, India, Japan and Australia.
– The report offers country level GIS market value and volume for the historical (2010-2015) and forecast (2016-2020) periods.
– It provides competitive landscape at country level for the year 2015 and profiles of major players in GIS market.
– Qualitative analysis key market drivers and restraints and analysis of their impacts in GIS market is also discussed.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to –
– Facilitate decision-making by analyzing historical and forecast data on GIS market
– Develop strategies based on developments in the GIS market
– Identify key partners and business-development avenues, based on an understanding of the movements of the major competitors in the GIS market
– Respond to your competitors’ business structure, strategies and prospects

世界の産業動向ニュース

手術室用装置の世界市場分析・予測

2017年3月6日 // 0 Comments

MediPoint: Operating Room Equipment – Global Analysis and Market Forecasts
Summary

The ubiquity of operating tables, surgical lights, and supply units in operating rooms throughout the world has led to a steadily growing market for these standard OR equipment. Surgeons worldwide have always required the basic set of equipment to perform procedures. The market dynamics within each of the OR segments deserves analysis and explanation. OR tables, which can broadly be divided into manual and powered equipment, are experiencing unique technological and adoption trends in different geographies. In the surgical lighting space, halogen bulb lamps are giving way to modern light-emitting diode (LED) lights, which emit lower amounts of heat. An increased emphasis on equipment accessibility and ease of use is driving the overhead supply boom business forward.

OR equipment are experiencing steady growth across many countries. Emerging markets are expected to demonstrate the highest growth among the 10 market covered in the report, which are the US, France, Germany, Italy, Spain, UK, Japan, China, India, and Brazil.

The taxonomy of OR equipment included in this report covers OR tables, OR lights, and surgical booms.

Maquet Getinge, Steris, and Stryker are the key players in the international OR equipment space. These companies have maintained success by making important acquisitions, establishing beneficial partnerships, and providing a comprehensive portfolio of prominent brands to their customers.

The entire market will be driven by increasing volumes of surgical procedures (laparoscopic procedures, robotic surgeries), and increasing access to better surgical care.

Industry KOLs have highlighted the impact of sole sourcing and innovate portfolios on the entire market.

Highlights

Key Questions Answered

– What is the current and future OR Equipment market outlook in the developed and emerging markets? What trends are affecting the global market?
– Which are the key, high growth sectors of interest? Which markets segments are growing the fastest?
– What are the unmet needs with brands currently on the market? How will future developments fulfill these unmet needs?
– What are the challenges that have hindered widespread adoption?
– How will emerging trends and changing market landscapes affect the future of this space?

Key Findings

– Emerging economies are seeing the highest growth in the global OR equipment market.
– OR tables make up the largest portion of the OR equipment market as defined in our taxonomy
– The most successful firms involved are providing comprehensive portfolios, undertaking key M&A’s, fostering innovation, and wisely offering cost-saving bundling contracts to hospitals.
– Rising numbers of different surgical procedures are the primary drivers of the OR equipment market. Despite respectable adoption, unmet needs and non-clinical barriers remain a challenge.

Scope

– Overview of the major brands of OR tables, OR lights, and surgical booms in the market
– Annualized total market revenue by segment and market outlooks by country through 2023
– Key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, evaluating market access, and implications of the emerging technologies on the market.
– Analysis of the current and future market competition in the market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to –
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track device sales in the global and country-specific markets from 2014-2023.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

世界の産業動向ニュース

火力発電向けボイラー・タービン・発電機（BTG）の世界市場：市場規模、競争状況、主要国分析、予測

2017年3月6日 // 0 Comments

Boilers, Turbines and Generators (BTG) for Thermal Power – Market Size, Competitive Landscape, Key Country Analysis and Forecasts to 2020
Summary

GlobalData’s latest report “Boilers, Turbines and Generators (BTG) for Thermal Power – Market Size, Competitive Landscape, Key Country Analysis and Forecasts to 2020” provides comprehensive information and understanding of the BTG market. The report offers in-depth analysis of BTG market at global, regional (Asia-Pacific, Americas, Europe, and Middle East and Africa) and key countries (US, China, India, Republic of Korea, Germany, UK, Saudi Arabia, South Africa, Egypt, Turkey, Poland, and Nigeria) level. The report analyzes the global and regional BTG market value and size for the historic (2010-2015) and forecast (2016-2020) periods. The report also offers the country-level analysis of BTG market value, size and average price by capacity segment for the historic and forecast periods. The report covers the drivers and restraints affecting the BTG market and the competitive landscape for respective countries in 2015. The report is built using data and information sourced from primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report analyses BTG market. Its scope includes –
– Analysis of the growth of the BTG market with a focus on market value and size in Asia-Pacific, Americas and Europe.
– Apart from global and regional analysis, the report provides BTG market analysis in key countries including the US, China, India, Vietnam, Republic of Korea, Indonesia, Thailand, Malaysia, Philippines, Germany, the UK, Saudi Arabia, South Africa, Egypt, Turkey, Poland and Nigeria.
– The report offers country level BTG market value, size and average price analysis for the historical (2010-2015) and forecast (2016-2020) periods.
– It provides market share of major players at global level and in respective countries prevailing in the BTG market in 2015.
– Qualitative analysis of key regulations, market drivers and restraints impacting the BTG industry.

Reasons to buy

– The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to –
– Facilitate decision-making by analyzing historical and forecast data on BTG market
– Develop strategies based on developments in the BTG market
– Identify key partners and business-development avenues, based on an understanding of the movements of the major competitors in the BTG market
– Respond to your competitors’ business structure, strategies and prospects

世界の産業動向ニュース

非小細胞肺癌（NSCLC）治療の世界市場：医薬品予測・市場分析（～2025）

2017年3月6日 // 0 Comments

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) – Global Drug Forecast and Market Analysis to 2025
Summary

Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted the treatment landscape towards personalized medicine.

For the purposes of this report, GlobalData considers the Global NSCLC market to include NSCLC-specific drug sales in the 8MM (US, 5EU [France, Germany Italy, Spain, and the UK], Japan, and China). The current market across these countries is dominated by the sale of major chemotherapy regimens, anti-angiogenic agents and targeted therapies for patients with EGFR+ and ALK+ NSCLC. GlobalData estimated that the Global NSCLC market was valued at $6.2b in 2015. The NSCLC therapeutics market is expected to grow at a positive CAGR of 15.7%, reaching 26.71b in the 8MM by 2025.

The growth of the NSCLC market during the forecast period will be driven partly by increasing incident cases of NSCLC in the US, 5EU, Japan, and China, as the population ages. In addition, the launch of premium-priced immuno-oncology (I/O) and targeted pipeline agents will drive the uptake of new therapies and prolong the duration of treatment in the first-line and beyond. The increased used of branded I/O therapies, such as Keytruda, Opdivo, and Tecentriq will be the primary driver of growth during the forecast period. The projected increase in mutation testing rate during the forecast period coupled with the launch of new generation EGFR and ALK TKIs, and BRAF inhibitors will significantly promote the sales of the targeted therapies, Tagrisso, Alecensa, and Tafinlar + Mekinist.

Highlights

Key Questions Answered

– Based on interviews with key opinion leaders (KOLs), GlobalData has identified the major unmet needs in the NSCLC marketplace. Will the leading pipeline agents fulfil these unmet needs during the forecast period (2015-2025)?
– What research and development (R&D) strategies will companies leverage to compete in the future NSCLC marketplace?
– Which pipeline products are poised to make a major clinical and commercial impact?
– What clinical and commercial factors are likely to influence NSCLC drug uptake in the 8MM?

Key Findings

– The increasing incorporation of premium-priced immune checkpoint inhibitor immunotherapies into the NSCLC treatment algorithm, particularly in the first-line setting, will be one major driver. Collectively, immunotherapies will reach $17.5B in sales by 2025, accounting for roughly 65% of total sales in the NSCLC market. Of the $17.5B total, Keytruda, Opdivo, and Tecentriq are projected to contribute $5.2B, $5.5B, and $2.8B, respectively.
– The increasing incidence of NSCLC in the 8MM will also drive growth. China, in particular, will see its NSCLC incident cases increase dramatically over the forecast period, at an Annual Growth Rate (AGR) of 4.7%. Overall, across the 8MM, the incidence of NSCLC is expected to increase at an AGR of 3.1% from 2015-2025. This increase, coupled with an anticipated increase in branded therapy prescriptions in China, will drive the growth of both the Chinese and global NSCLC markets over the forecast period.
– Patent expiration of several blockbuster drugs, including Tarceva and Alimta, and the uptake of generics will limit growth. GlobalData expects sales of the patented drug in the 8MM to decrease from $783M in 2015 to $18M by 2025. In addition, sales of Alimta will decrease from $2.1B in 2015 to $54M in 2025.
– An increasing emphasis on cost-consciousness is anticipated over the forecast period, which will limit premium pricing opportunities for developers of NSCLC pipeline agents. GlobalData expects this era of austerity and healthcare reform to make it increasingly more difficult for pharmaceutical companies to gain reimbursement approval for their new NSCLC therapies.

Scope

– Overview of NSCLC, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and current treatment options.
– Topline NSCLC drug market revenue from 2015-2025, annual cost of therapy (ACOT), and major product sales in 17 patient segments during the forecast period are included.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs, opportunities, R&D strategies, and clinical trial mapping for the NSCLC market.
– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of late-stage pipeline products.
– Analysis of the current and future market competition in the global NSCLC market. Insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to –
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global NSCLC therapeutics market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the NSCLC market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

1 2 3 4

GlobalData アーカイブ - Page 2 of 4 - 世界の産業動向ニュース
Copyright (c) WorldMarketsData.com

[Sitemap]